News
Delhi High Court Affirms Stronger Protection for Pharmaceutical Trademarks
16 September 2026
The Delhi High Court on September 14, 2026, issued a ruling in a rectification petition filed by Dr. Reddy's Laboratories Limited against Razenta Pharmaceuticals Private Limited's registered trademark DAPLOGIN in Class 5.
The court reaffirmed the principle of granting higher protection to pharmaceutical trademarks due to the sensitive nature of the goods and the potential for consumer confusion in the healthcare sector.
The decision emphasizes stricter scrutiny for marks in the pharmaceutical domain to prevent any likelihood of deception or confusion among consumers seeking medicines.
Sources: https://trademarklawyermagazine.com/trademark-news/ https://www.law360.com/intellectual-property-uk
Share